Dr. Patrick Jay Lynn, MD

Dr. Lynn practices at Atrium Health Floyd Cherokee Medical Center in Centre, Alabama, part of Advocate Health.

Dr. Lynn's NPI, 1740549138, was assigned on May 7, 2012. Dr. Lynn graduated from University of Florida College of Medicine in 2012. Dr. Lynn holds Georgia license 070480.

Dr. Lynn's primary practice is Atrium Health Floyd Cherokee Medical Center, at 400 Northwood Dr, Centre, AL 35960 in Cherokee County. The practice phone is (256) 927-5531.

Dr. Lynn's primary practice is Atrium Health Floyd Cherokee Medical Center in Centre, Alabama, part of Advocate Health. Dr. Lynn is also affiliated with Atrium Health Floyd Medical Center. The medical group on file is Atrium Health Floyd Primary Care. Dmand AI also links Dr. Lynn to 1 more hospital, 7 medical groups and 6 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lynn practices, 9 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Lynn's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Dr. Lynn's licenses on file in 2 states: Georgia and Alabama.

CMS data shows 203 Medicare services from Dr. Lynn across 2 procedure codes in 2024, for 226 Medicare patients. Medicare paid $21,344 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 226 Medicare patients who saw Dr. Lynn in 2024. The largest group is 75 to 84, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lynn's median patient age at 40, with 59% women.

In 2024, Dr. Lynn wrote 519 Medicare Part D claims for 336 patients. 93% of them were for generic drugs. CMS names the drug for 328 of them, across 14 drugs with 11 or more claims each, at $2,015 in total drug cost. In 2023, CMS named 355 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lynn for performance year 2024, reported as part of a group. Dr. Lynn accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Lynn from 2 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $24.

Dr. Lynn graduated from University of Florida College of Medicine in 2012.